Economic growth in Asia will be almost 6% in 2014 (excluding Japan), compared with 1.5% in the EU and 2.5% in the U.S. Asia's growth will be led by China, which is expected to expand over 7% this year. The economies of... Read More
After a drug has been approved by the China Food and Drug Administration (CFDA), it can take another year and a half until the pharmaceutical product can actually be prescribed by a doctor. To shorten this process, some drug companies begin the... Read More
已获得中国食品药品监督管理局（CFDA）批准的药物，通常需要一年半的时间医生才可以给病人使用。为尽快让病人使用上已经批准的药物，一些制药公司开始在药物获得批准以前，就开始着手价格审批，招投标和医院上市的工作。中国的药品定价，是指医院进行的药品定价和药品采购。确定进口药品的价格与设定国产药物的价格，有所不同。 Read More
Japan has unique social customs and a distinct group mentality that greatly affects how business is conducted there. Western medical companies looking to expand to Japan will first need to properly understand Japanese business culture and etiquette. This presentation covers various essential aspects... Read More
The Chinese pharmaceutical market was worth an estimated $75 billion in 2013. The market grew 20% year after year during the past decade and is projected to continue expanding at the rate of 17.5% per year through 2020. Currently the third largest... Read More
On May 8, 2014, China's National Development and Reform Commission (NDRC) announced that retail price caps for a list of cheap, basic drugs would be relaxed, effective immediately. Instead, pharmaceutical companies will be able to set retail prices based on their costs... Read More
On April 14, 2014, the Korean Ministry of Food and Drug Safety (MFDS) announced that it is planning to test random drug samples of products currently on the market, starting in June 2014. Both generic drugs and original drugs will be tested,... Read More
2014年5月8日，中国国家发展和改革委员会 (国家发改委) 公布，将放松对基本药物清单中零售低价药价格上限的控制，并且立刻生效。制药公司可以根据生产成本来设定零售价格。受这一政策影响的药物包括止痛药和抗生素，如阿莫西林。中国政府希望，这一政策将促使厂商提高药品质量，增加药品供应。 Read More
Medical experts estimate that about 10 million Chinese patients have some type of rare disease. Specific legislation on orphan drugs is still lacking in China. However, since 2009, a fast approval process for drugs related to some rare diseases has been in... Read More
2014年4月14日，朝鲜食品药品安全部（MFDS）宣布，从2014年6月开始它计划随机抽查已上市药品的生物等效性。仿制药和原创药都在测试范围里。这项措施的目的是提高仿制药的市场在韩国的质量。 Read More